The End of Easy Generics: How Monopsony, Deflation, and the China Tether Are Forcing Indian Pharma Up the Value Chain

northpath issue71 cover

This essay is for Manish Goel Plus members.

Join to unlock all 115 premium essays — the complete NorthPath archive plus every new daily edition. €15/month or €150/year. The latest Letter is always free.

🔒 115 ESSAYS IN THE ARCHIVE — AND COUNTING

Subscribe to read →

Already a member? Sign in